These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 11880221)

  • 1. Hyperinsulinemia, dyslipidemia, and obesity as risk factors for hospitalized gallbladder disease. A prospective study.
    Boland LL; Folsom AR; Rosamond WD;
    Ann Epidemiol; 2002 Feb; 12(2):131-40. PubMed ID: 11880221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Body mass index, abdominal fatness and the risk of gallbladder disease.
    Aune D; Norat T; Vatten LJ
    Eur J Epidemiol; 2015 Sep; 30(9):1009-19. PubMed ID: 26374741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperinsulinemia is associated with the incidence of hypertension and dyslipidemia in middle-aged men.
    Salonen JT; Lakka TA; Lakka HM; Valkonen VP; Everson SA; Kaplan GA
    Diabetes; 1998 Feb; 47(2):270-5. PubMed ID: 9519724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apolipoprotein E genotype and gallbladder disease risk in a large population-based cohort.
    Boland LL; Folsom AR; Boerwinkle E;
    Ann Epidemiol; 2006 Oct; 16(10):763-9. PubMed ID: 16882462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Central adiposity and gallbladder disease in Mexican Americans.
    Haffner SM; Diehl AK; Stern MP; Hazuda HP
    Am J Epidemiol; 1989 Mar; 129(3):587-95. PubMed ID: 2916552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship of serum leptin concentration and other measures of adiposity with gallbladder disease.
    Ruhl CE; Everhart JE
    Hepatology; 2001 Nov; 34(5):877-83. PubMed ID: 11679957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Obesity and gallbladder diseases].
    Jeong SU; Lee SK
    Korean J Gastroenterol; 2012 Jan; 59(1):27-34. PubMed ID: 22289951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective study of clinical gallbladder disease and its association with obesity, physical activity, and other factors.
    Kato I; Nomura A; Stemmermann GN; Chyou PH
    Dig Dis Sci; 1992 May; 37(5):784-90. PubMed ID: 1563324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The central roles of obesity-associated dyslipidaemia, endothelial activation and cytokines in the Metabolic Syndrome--an analysis by structural equation modelling.
    Chan JC; Cheung JC; Stehouwer CD; Emeis JJ; Tong PC; Ko GT; Yudkin JS
    Int J Obes Relat Metab Disord; 2002 Jul; 26(7):994-1008. PubMed ID: 12080455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gallbladder disease in hyperlipoproteinaemia.
    Einarsson K; Hellström K; Kallner M
    Lancet; 1975 Mar; 1(7905):484-7. PubMed ID: 46958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma lipids and gallbladder disease.
    Mohr GC; Kritz-Silverstein D; Barrett-Connor E
    Am J Epidemiol; 1991 Jul; 134(1):78-85. PubMed ID: 1853863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low incidence of hospitalization with gallbladder disease among blacks in the United States.
    Sichieri R; Everhart JE; Roth HP
    Am J Epidemiol; 1990 May; 131(5):826-35. PubMed ID: 2321626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Body mass index, cigarette smoking, and other characteristics as predictors of self-reported, physician-diagnosed gallbladder disease in male college alumni.
    Sahi T; Paffenbarger RS; Hsieh CC; Lee IM
    Am J Epidemiol; 1998 Apr; 147(7):644-51. PubMed ID: 9554603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk variable clustering in the insulin resistance syndrome. The Framingham Offspring Study.
    Meigs JB; D'Agostino RB; Wilson PW; Cupples LA; Nathan DM; Singer DE
    Diabetes; 1997 Oct; 46(10):1594-600. PubMed ID: 9313755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Which measure of body fat distribution is best for epidemiologic research?
    Mueller WH; Wear ML; Hanis CL; Emerson JB; Barton SA; Hewett-Emmett D; Schull WJ
    Am J Epidemiol; 1991 May; 133(9):858-69. PubMed ID: 2028976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Obesity and cholecystectomy among women: implications for prevention.
    Petitti DB; Sidney S
    Am J Prev Med; 1988; 4(6):327-30. PubMed ID: 3228528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of obesity and hyperinsulinemia in the development of metabolic syndrome: San Antonio Heart Study.
    Han TS; Williams K; Sattar N; Hunt KJ; Lean ME; Haffner SM
    Obes Res; 2002 Sep; 10(9):923-31. PubMed ID: 12226141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The prevalence of liver and gallbladder pathologies in overweight and obese patients].
    Popova IR; Pavlov ChS; Glushenkov DV; Drapkina OM; Ivashkin VT
    Klin Med (Mosk); 2012; 90(10):38-43. PubMed ID: 23285761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship of the metabolic syndrome and obesity to polycystic ovary syndrome: a controlled, population-based study.
    Korhonen S; Hippeläinen M; Niskanen L; Vanhala M; Saarikoski S
    Am J Obstet Gynecol; 2001 Feb; 184(3):289-96. PubMed ID: 11228476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of fasting hyperinsulinemia to prediction of atherosclerotic cardiovascular disease status in 293 hyperlipidemic patients.
    Glueck CJ; Lang JE; Tracy T; Sieve-Smith L; Wang P
    Metabolism; 1999 Nov; 48(11):1437-44. PubMed ID: 10582554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.